MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with V

Valproic acid

Valproic acid 125mg gastro-resistant capsules

No stability information

Stability notes for Valproic acid 125mg gastro-resistant capsules

There are no stability notes for this medicine.

Supplier

Depakote 125mg sprinkle gastro-resistant capsules (Imported (United States))

Valproic acid 150mg gastro-resistant capsules

Use with caution

Stability notes for Valproic acid 150mg gastro-resistant capsules

Valproate-containing medicines must always be dispensed in the manufacturer’s original full pack unless there are exceptional circumstances. The Patient Information Leaflet should be provided.

Protect from light. Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.

Provenance

This recommendation is based on the products Convulex 150mg Capsules (G.L Pharma UK Limited).

Supplier

Convulex 150mg gastro-resistant capsules (G.L. Pharma UK Ltd)

Valproic acid 250mg gastro-resistant tablets

Use with caution

Stability notes for Valproic acid 250mg gastro-resistant tablets

Valproate-containing medicines must always be dispensed in the manufacturer’s original full pack unless there are exceptional circumstances. The Patient Information Leaflet should be provided.

No stability data in MCAs available.

Provenance

This recommendation is based on the product Depakote 250mg gastro-resistant tablets (SANOFI).

Suppliers (5) of Valproic acid 250mg gastro-resistant tablets
Belvo 250mg gastro-resistant tablets (Consilient Health Ltd)
Depakote 250mg gastro-resistant tablets (CST Pharma Ltd)
Depakote 250mg gastro-resistant tablets (Necessity Supplies Ltd)
Depakote 250mg gastro-resistant tablets (Sanofi)
Syonell 250mg gastro-resistant tablets (Lupin Healthcare (UK) Ltd)

Valproic acid 300mg gastro-resistant capsules

Use with caution

Stability notes for Valproic acid 300mg gastro-resistant capsules

Valproate-containing medicines must always be dispensed in the manufacturer’s original full pack unless there are exceptional circumstances. The Patient Information Leaflet should be provided.

Protect from light. Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.

Provenance

This recommendation is based on the products Convulex 300mg Capsules (G.L Pharma UK Limited).

Supplier

Convulex 300mg gastro-resistant capsules (G.L. Pharma UK Ltd)

Valproic acid 500mg gastro-resistant capsules

Use with caution

Stability notes for Valproic acid 500mg gastro-resistant capsules

Valproate-containing medicines must always be dispensed in the manufacturer’s original full pack unless there are exceptional circumstances. The Patient Information Leaflet should be provided.

Protect from light. Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.

Provenance

This recommendation is based on the products Convulex 500mg Capsules (G.L Pharma UK Limited).

Supplier

Convulex 500mg gastro-resistant capsules (G.L. Pharma UK Ltd)

Valproic acid 500mg gastro-resistant tablets

Use with caution

Stability notes for Valproic acid 500mg gastro-resistant tablets

Valproate-containing medicines must always be dispensed in the manufacturer’s original full pack unless there are exceptional circumstances. The Patient Information Leaflet should be provided.

No stability data in MCAs available.

Provenance

This recommendation is based on the product Depakote 500mg gastro-resistant tablets (SANOFI).

Suppliers (5) of Valproic acid 500mg gastro-resistant tablets
Belvo 500mg gastro-resistant tablets (Consilient Health Ltd)
Depakote 500mg gastro-resistant tablets (CST Pharma Ltd)
Depakote 500mg gastro-resistant tablets (Necessity Supplies Ltd)
Depakote 500mg gastro-resistant tablets (Sanofi)
Syonell 500mg gastro-resistant tablets (Lupin Healthcare (UK) Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.